Peter M. Hecht

Insider Reports History

Entity
Individual
Location
C/O Cyclerion Therapeutics, Inc., 301 Binney Street, Cambridge, MA
Signature
/s/ Peter M. Hecht
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Peter M. Hecht:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyclerion Therapeutics, Inc. Director, 10%+ Owner Common Stock 377K $1.28M $3.40 Jan 1, 2024 Direct
Cyclerion Therapeutics, Inc. Director, 10%+ Owner Common Stock 24 $81.50 $3.40 Jan 1, 2024 The 2000 Trust for Alexis Mae Hecht
Cyclerion Therapeutics, Inc. Director, 10%+ Owner Common Stock 24 $81.50 $3.40 Jan 1, 2024 The 2000 Trust for Malcolm Peter Hecht
Cyclerion Therapeutics, Inc. Director, 10%+ Owner Common Stock 24 $81.50 $3.40 Jan 1, 2024 The 2000 Trust for Zoe Niovi Hecht
Cyclerion Therapeutics, Inc. Director, 10%+ Owner Series A Convertible Preferred Stock 351K May 19, 2023 Direct

Insider Reports Filed by Peter M. Hecht

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CYCN Cyclerion Therapeutics, Inc. Jan 1, 2024 1 $0 4 Jan 26, 2024 Director, 10%+ Owner
CYCN Cyclerion Therapeutics, Inc. Nov 30, 2023 2 $0 4 Dec 4, 2023 Director, 10%+ Owner
CYCN Cyclerion Therapeutics, Inc. May 19, 2023 2 $5M 4 May 22, 2023 Chief Executive Officer, Director, 10%+ Owner
CYCN Cyclerion Therapeutics, Inc. Jan 3, 2022 2 $0 4 Jan 24, 2022 Chief Executive Officer, Director
CYCN Cyclerion Therapeutics, Inc. Jun 3, 2021 1 $2.7M 4 Jun 7, 2021 Chief Executive Officer, Director
CYCN Cyclerion Therapeutics, Inc. May 6, 2021 1 $734K 4 May 10, 2021 Chief Executive Officer, Director